1. Pink Sheet
  2. >>Vaccines

With New Rare Blood Clot Warning, J&J COVID-19 Vaccine Rollout Resumes In EU

Countries May Impose Age Restrictions

 
• By Andrew McConaghie

Similarities to AstraZeneca blood clots are clear, but more research needed before any ‘class effect’ conclusions can be drawn.

Janssen Leiden Netherlands
The Janssen vaccine's development was co-ordinated in Leiden, The Netherlands. The country was the first in the EU to say it would begin using the shot this week.

The rollout of Johnson & Johnson’s COVID-19 vaccine is to resume this week in the EU, after the bloc’s medicines regulator backed its benefit/risk profile despite a possible link to very rare blood clots.

The European Medicines Agency has advised that the one-shot vaccine should carry new safety warnings, but stressed that its benefits in

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Vaccines

More from Pink Sheet

Brazil To Upgrade Pricing Framework To Keep Up With Market Developments

 
• By Francesca Bruce

Brazil plans to clarify its medicine pricing framework, for example by outlining the procedures for setting medicine prices and bring it up to date with recent developments in the sector.

England: HTA Sandbox Helping To Assess ‘Challenging’ Drugs And Indications

 
• By Eliza Slawther

England’s health technology assessment institute explains how its sandbox environment is helping to test new evaluation methods for drugs or indications with which it does not have experience, such as metabolic dysfunction-associated steatohepatitis.

Unlocking Opportunities: How To Engage With The EMA On Animal Testing Alternatives

 
• By Neena Brizmohun

The European Medicines Agency, like its counterpart in the US, is increasingly focusing on the use of alternatives to animal testing.